Dr Alex Davenport, Senior Scientist. 2021. bit.bio talk at ELRIG Cell & Gene Therapy
In this presentation, our Senior Scientist, Dr Alex Davenport, discusses how cellular reprogramming enables the precise and scalable manufacturing of human cells for therapeutic applications. Davenport highlights how having access to a reliable and consistent source of human cells is a potential game changer for cell therapies.
Presenting key examples from external partners and collaborators, Davenport demonstrates how bit.bio’s core technology, opti-ox™, has been applied to created megakaryocytes, myogenic precursors and astrocytes.
Watch now to discover how bit.bio’s core technology: